Other Species / Isoforms
  FAF1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K139-ub
ELQIPVSkMLLkGWk
0 22
FAF1 (human) ELQIPVSkMLLkGWk K139-ub
FAF1 iso2 (human) ELQIPVSKMLLKGWK K139
FAF1 (mouse) ELQIPVPkMLLkGWk K138-ub
FAF1 (rat) ELQIPVPKMLLKGWK K138
K143-ub
PVSkMLLkGWkTGDV
0 15
FAF1 (human) PVSkMLLkGWkTGDV K143-ub
FAF1 iso2 (human) PVSKMLLKGWKTGDV K143
FAF1 (mouse) PVPkMLLkGWkTGDV K142-ub
FAF1 (rat) PVPKMLLKGWKTGDV K142
K146-ac
kMLLkGWkTGDVEDS
0 1
FAF1 (human) kMLLkGWkTGDVEDS K146-ac
FAF1 iso2 (human) KMLLKGWKTGDVEDS K146
FAF1 (mouse) kMLLkGWKTGDVEDS K145
FAF1 (rat) KMLLKGWKTGDVEDS K145
K146-ub
kMLLkGWkTGDVEDS
0 92
FAF1 (human) kMLLkGWkTGDVEDS K146-ub
FAF1 iso2 (human) KMLLKGWKTGDVEDS K146
FAF1 (mouse) kMLLkGWkTGDVEDS K145-ub
FAF1 (rat) KMLLKGWKTGDVEDS K145
K157-ac
VEDSTVLkSLHLPkN
0 1
FAF1 (human) VEDSTVLkSLHLPkN K157-ac
FAF1 iso2 (human) VEDSTVLKSLHLPKN K157
FAF1 (mouse) VEDSTVLKSLHLPKN K156
FAF1 (rat) VEDSTVLKSLHLPKN K156
K157-ub
VEDSTVLkSLHLPkN
Upstream
0 56
Treatment
  • vorinostat
FAF1 (human) VEDSTVLkSLHLPkN K157-ub
FAF1 iso2 (human) VEDSTVLKSLHLPKN K157
FAF1 (mouse) VEDSTVLkSLHLPKN K156-ub
FAF1 (rat) VEDSTVLKSLHLPKN K156
K163-ub
LkSLHLPkNNSLYVL
0 6
FAF1 (human) LkSLHLPkNNSLYVL K163-ub
FAF1 iso2 (human) LKSLHLPKNNSLYVL K163
FAF1 (mouse) LkSLHLPKNNSLYVL K162
FAF1 (rat) LKSLHLPKNNSLYVL K162
Y207
HREVQREYNLNFSGS
0 1
FAF1 (human) HREVQREYNLNFSGS Y207
FAF1 iso2 (human) gap -
FAF1 (mouse) HREVQREyNLNFsGS Y206-p
FAF1 (rat) HREVQREYNLNFSGS Y206
S212
REYNLNFSGSSTIQE
0 1
FAF1 (human) REYNLNFSGSSTIQE S212
FAF1 iso2 (human) gap -
FAF1 (mouse) REyNLNFsGSstVQE S211-p
FAF1 (rat) REYNLNFSGSSTVQE S211
S215
NLNFSGSSTIQEVkR
0 1
FAF1 (human) NLNFSGSSTIQEVkR S215
FAF1 iso2 (human) gap -
FAF1 (mouse) NLNFsGSstVQEVkR S214-p
FAF1 (rat) NLNFSGSSTVQEVKR S214
T216
LNFSGSSTIQEVkRN
0 1
FAF1 (human) LNFSGSSTIQEVkRN T216
FAF1 iso2 (human) gap -
FAF1 (mouse) LNFsGSstVQEVkRN T215-p
FAF1 (rat) LNFSGSSTVQEVKRN T215
K221-ub
SSTIQEVkRNVyDLT
0 23
FAF1 (human) SSTIQEVkRNVyDLT K221-ub
FAF1 iso2 (human) gap -
FAF1 (mouse) SstVQEVkRNVyDLT K220-ub
FAF1 (rat) SSTVQEVKRNVYDLT K220
Y225-p
QEVkRNVyDLTSIPV
0 16
FAF1 (human) QEVkRNVyDLTSIPV Y225-p
FAF1 iso2 (human) gap -
FAF1 (mouse) QEVkRNVyDLTSIPV Y224-p
FAF1 (rat) QEVKRNVYDLTSIPV Y224
T264-p
SYPCHRLtVGRRssP
0 1
FAF1 (human) SYPCHRLtVGRRssP T264-p
FAF1 iso2 (human) gap -
FAF1 (mouse) SYPCHRLTVGRRtsP T263
FAF1 (rat) SYPCHRLTVGRRTsP T263
S269-p
RLtVGRRssPAQtRE
0 4
FAF1 (human) RLtVGRRssPAQtRE S269-p
FAF1 iso2 (human) gap -
FAF1 (mouse) RLTVGRRtsPVQtRE T268-p
FAF1 (rat) RLTVGRRTsPVQTRE T268
S270-p
LtVGRRssPAQtREQ
Upstream
0 28
Treatment
  • nocodazole
FAF1 (human) LtVGRRssPAQtREQ S270-p
FAF1 iso2 (human) gap -
FAF1 (mouse) LTVGRRtsPVQtREQ S269-p
FAF1 (rat) LTVGRRTsPVQTREQ S269-p
T274-p
RRssPAQtREQSEEQ
Upstream
0 5
Treatment
  • nocodazole
FAF1 (human) RRssPAQtREQSEEQ T274-p
FAF1 iso2 (human) gap -
FAF1 (mouse) RRtsPVQtREQSEEQ T273-p
FAF1 (rat) RRTsPVQTREQSEEQ T273
S289-p
ITDVHMVsDsDGDDF
Upstream
Downstream
3 2
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • AurA (human)
  • CK2A1 (human)
Putative in vivo kinases:
  • AurA (human)
Treatment
  • taxol
  • VX-680
FAF1 (human) ITDVHMVsDsDGDDF S289-p
FAF1 iso2 (human) gap -
FAF1 (mouse) STDVHMVSDSDGDDF S288
FAF1 (rat) STVVHMVSDSDGDDF S288
S291-p
DVHMVsDsDGDDFED
Upstream
Downstream
3 2
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • AurA (human)
  • CK2A1 (human)
Putative in vivo kinases:
  • AurA (human)
Treatment
  • taxol
  • VX-680
FAF1 (human) DVHMVsDsDGDDFED S291-p
FAF1 iso2 (human) gap -
FAF1 (mouse) DVHMVSDSDGDDFED S290
FAF1 (rat) VVHMVSDSDGDDFED S290
K319-ub
MASSALRksPMMPEN
0 1
FAF1 (human) MASSALRksPMMPEN K319-ub
FAF1 iso2 (human) gap -
FAF1 (mouse) MASSTLRKsPMMPEN K318
FAF1 (rat) MASSTMRKsPMMPEN K318
S320-p
ASSALRksPMMPENA
0 24
FAF1 (human) ASSALRksPMMPENA S320-p
FAF1 iso2 (human) gap -
FAF1 (mouse) ASSTLRKsPMMPENA S319-p
FAF1 (rat) ASSTMRKsPMMPENA S319-p
S342-p
LQFTAEFssRYGDCH
0 1
FAF1 (human) LQFTAEFssRYGDCH S342-p
FAF1 iso2 (human) gap -
FAF1 (mouse) LQFTAEFSSRYGDCH S341
FAF1 (rat) LQFTAEFSSRYGDCH S341
S343-p
QFTAEFssRYGDCHP
0 1
FAF1 (human) QFTAEFssRYGDCHP S343-p
FAF1 iso2 (human) gap -
FAF1 (mouse) QFTAEFSSRYGDCHP S342
FAF1 (rat) QFTAEFSSRYGDCHP S342
K444-ub
AQTIRTQkTDQFPLF
0 19
FAF1 (human) AQTIRTQkTDQFPLF K444-ub
FAF1 iso2 (human) AQTIRTQKTDQFPLF K292
FAF1 (mouse) AQTIRTQkTDQFPLF K443-ub
FAF1 (rat) AQTIRTQKTDQFPLF K443
K457-ub
LFLIIMGkRSSNEVL
0 4
FAF1 (human) LFLIIMGkRSSNEVL K457-ub
FAF1 iso2 (human) LFLIIMGKRSSNEVL K305
FAF1 (mouse) LFLIIMGKRSSNEVL K456
FAF1 (rat) LFLIIMGKRSSNEVL K456
K508-sm
REARENVkREQDEAY
0 1
FAF1 (human) REARENVkREQDEAY K508-sm
FAF1 iso2 (human) REARENVKREQDEAY K356
FAF1 (mouse) REARENVKREQDEAY K507
FAF1 (rat) REARENVKREQDEAY K507
K544-ub
FRLEQIRkEQEEERE
0 1
FAF1 (human) FRLEQIRkEQEEERE K544-ub
FAF1 iso2 (human) FRLEQIRKEQEEERE K392
FAF1 (mouse) FRLEQIRKEQEEERE K543
FAF1 (rat) FRLEQIRKEQEEERE K543
S556-p
EREAIRLsLEQALPP
Upstream
Downstream
1 3
Effects on Modified Protein
  • acetylation
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • signaling pathway regulation
  • transcription, induced
Kinase, in vitro:
  • IKKE (human)
Putative in vivo kinases:
  • IKKE (human)
Regulatory protein:
  • TBK1 (human)
Treatment
  • chloroquine
  • virus infection
FAF1 (human) EREAIRLsLEQALPP S556-p
FAF1 iso2 (human) EREAIRLSLEQALPP S404
FAF1 (mouse) EREAIRLsLEQALPP S555-p
FAF1 (rat) EREAIRLSLEQALPP S555
K566-ub
QALPPEPkEENAEPV
0 1
FAF1 (human) QALPPEPkEENAEPV K566-ub
FAF1 iso2 (human) QALPPEPKEENAEPV K414
FAF1 (mouse) QALPPEPKEENAEPV K565
FAF1 (rat) QALPPEPEEENAEPV E565
K575-ub
ENAEPVSkLRIRtPs
0 2
FAF1 (human) ENAEPVSkLRIRtPs K575-ub
FAF1 iso2 (human) ENAEPVSKLRIRtPs K423
FAF1 (mouse) ENAEPVSKLRIRtPs K574
FAF1 (rat) ENAEPVSKLRIRTPs K574
T580-p
VSkLRIRtPsGEFLE
Upstream
0 32
Treatment
  • rapamycin
  • U0126
FAF1 (human) VSkLRIRtPsGEFLE T580-p
FAF1 iso2 (human) VSKLRIRtPsGEFLE T428-p
FAF1 (mouse) VSKLRIRtPsGEFLE T579-p
FAF1 (rat) VSKLRIRTPsGEFLE T579
S582-p
kLRIRtPsGEFLERR
Upstream
Downstream
2 252
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Kinase, in vitro:
  • Akt1 (human)
Putative in vivo kinases:
  • Akt1 (human)
FAF1 (human) kLRIRtPsGEFLERR S582-p
FAF1 iso2 (human) KLRIRtPsGEFLERR S430-p
FAF1 (mouse) KLRIRtPsGEFLERR S581-p
FAF1 (rat) KLRIRTPsGEFLERR S581-p
K631-ub
VTQLDPNkSLLEVkL
0 1
FAF1 (human) VTQLDPNkSLLEVkL K631-ub
FAF1 iso2 (human) VTQLDPNKSLLEVKL K479
FAF1 (mouse) VTQLDPNKSLLEVNL K630
FAF1 (rat) VTQLDPNKSLLEVNL K630
K637-ub
NkSLLEVkLFPQETL
0 3
FAF1 (human) NkSLLEVkLFPQETL K637-ub
FAF1 iso2 (human) NKSLLEVKLFPQETL K485
FAF1 (mouse) NKSLLEVNLFPQETL N636
FAF1 (rat) NKSLLEVNLFPQETL N636